MetaCap

Aspen Neuroscience Inc. Company Profile

NASDAQ: ASPEHealth CareBiotechnology: Pharmaceutical PreparationsUSD

12.42+0.03 (+0.24%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Aspen Neuroscience at a glance

Aspen Neuroscience Inc. (NASDAQ: ASPE) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in San Diego, CA. Aspen Neuroscience is led by Dr. Damien McDevitt Ph.D. and employs about 120 people. The company's shares have traded publicly since 2026.

At a market capitalization of $360.3 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0002124080, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Aspen Neuroscience do?

Aspen Neuroscience, Inc. develops autologous induced pluripotent stem cell (iPSC)-derived cell replacement therapies for neurodegenerative diseases. The company's develops ANPD001, an investigational single-dose, autologous dopaminergic neuronal precursor cell (DANPC) therapy for Parkinson's disease. It operates in the United States. The company also advances additional cell replacement candidates targeting both sporadic and genetic forms of Parkinson's disease, as well as other candidates for conditions of the central nervous system (CNS). Aspen Neuroscience, Inc. was formerly known as Aspen Biosciences, Inc. and changed its name to Aspen Neuroscience, Inc. in October 2018. Aspen Neuroscience, Inc. was incorporated in 2018 and is based in San Diego, California.

Business description based on the company's public filings.

Company information

Legal name
Aspen Neuroscience Inc.
Ticker
NASDAQ: ASPE
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Dr. Damien McDevitt Ph.D.
Employees
120
Headquarters
10835 Road to the Cure, San Diego, CA, United States
Phone
(858) 263-1222
IPO year
2026
Market cap
$360.28M
SEC CIK
0002124080

Companies similar to Aspen Neuroscience

ASPE peer companies
CompanyPrice% ChgMarket capCompare
PEPGPepGen Inc.3.78-3.82%$356.31Mvs ASPE
PBYIPuma Biotechnology Inc7.05-0.98%$364.47Mvs ASPE
PHATPhathom Pharmaceuticals Inc.4.66-8.27%$378.82Mvs ASPE
CTNMContineum Therapeutics Inc. Class A8.68-3.98%$340.83Mvs ASPE
IRDOpus Genetics Inc.3.99-2.21%$385.65Mvs ASPE
MPLTMapLight Therapeutics Inc.5.94-7.48%$330.12Mvs ASPE
AVTXAvalo Therapeutics Inc.6.76+0.15%$390.88Mvs ASPE
INOInovio Pharmaceuticals Inc.1.76+2.92%$329.66Mvs ASPE

Related